Fibrodysplasia Ossificans Progressiva (FOP) Withdrawn Phase 3 Trials for Garetosmab (DB16379)

Also known as: FOP / Fibrodysplasia Ossificans Progressiva / Myositis ossificans progressiva, unspecified site / Myositis ossificans progressiva / Progressive myositis ossificans / Progressive myositis ossificans (disorder)

IndicationStatusPhase
DBCOND0086420 (Fibrodysplasia Ossificans Progressiva (FOP))Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04577820Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)Treatment